Skip to content

NHF vs. COT in Hypoxemic Pandemic Viral Illness

Clinical Effects of Nasal High-flow Compared to Oxygen in Acute Viral Illness

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04750408
Acronym
HIVI
Enrollment
52
Registered
2021-02-11
Start date
2021-01-22
Completion date
2022-06-22
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Viral Bronchitis, Hypoxemic Respiratory Failure, Hypercapnic Respiratory Failure

Brief summary

The study compares oxygen and NHF in patients with acute viral illness. The duration will be 72h. After them physiological parameters and the outcome will be evaluated.

Interventions

COT describes the application of low-flow oxygen in any way (Hudson mask, nasal prongs,...).

F is combination of room air supplemented with oxygen can be better patients. This gas mixture will be provided to the patient with a specialized nasal prong.

Sponsors

Jens Bräunlich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* acute hyperemic viral illness * acute hyperemic or hypercapnia respiratory failure

Exclusion criteria

* intubation criteria * indication for NIV therapy * influences of primary endpoint (rip fracture, lung embolism) * tracheostomy * other interventional trials * noncompliance

Design outcomes

Primary

MeasureTime frameDescription
Rox index72 hours(SpO2/FiO2)/RR = index without a unit, mean Rox-index in the two groups, comparison between the groups (significant differences), physiological parameter, to assess differences between the two groups

Secondary

MeasureTime frameDescription
paCO2 in mmHg72 hoursphysiological parameter, to assess differences between the two groups
pH72 hoursphysiological parameter, to assess differences between the two groups
escalation of therapy72 hoursuse of noninvasive ventilation, intubation, to assess differences between the two groups
paO2 in mmHg72 hoursphysiological parameter, to assess differences between the two groups

Countries

Germany

Contacts

Primary ContactJens Bräunlich, MD
highflow@web.de+494921981598

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026